We are doubling our mammalian cell culture capacity in Europe!
Get More Info
About Us
Our Company
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
COVID-19 Response
Environment, Health & Safety
Group Privacy Policies
Our Services
Offerings
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
News & Resources
Press Releases
Events
Thought Leadership
Resources
Case Studies
Fact Sheets
Video Library
Media Kit
Careers
Job Openings
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Boulder Team
Longmont Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Search
Search
Toggle Menu
Search
Search
Toggle Menu
About Us
Toggle Menu
Our Company
Executive Leadership
Locations
Toggle Menu
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
Toggle Menu
COVID-19 Response
Environment, Health & Safety
Group Privacy Policies
Our Services
Toggle Menu
Offerings
Toggle Menu
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Toggle Menu
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
News & Resources
Toggle Menu
Press Releases
Events
Thought Leadership
Resources
Toggle Menu
Case Studies
Fact Sheets
Video Library
Media Kit
Careers
Toggle Menu
Job Openings
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Boulder Team
Longmont Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Our Company
About Us
Our History
Mission & Values
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
COVID-19 Policies
Environment, Health & Safety
Group Privacy Policies
Offerings
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fact Sheets
Global Manufacturing Capabilities (PDF)
CHEF1
TM
Expression Technology (PDF)
Analytical, Formulation and Stability (PDF)
Process Development (PDF)
Cell Therapy Capabilities (PDF)
Viral Vector Capabilities (PDF)
Plasmid DNA Capabilities (PDF)
Messenger RNA Capabilities (PDF)
News
Press Releases
Events
Thought Leadership
Resources
Case Studies
Fact Sheets
Video Library
Media Kit
Join Us
Career Opportunities
What Drives Us
Life at a CDMO
Diversity, Equity and Inclusion
Meet Our Teams
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Press Releases
Filter by Tag
All
Company News
Events
News
Partnership
Press Release
1 min read
AGC Biologics to Expand Biopharmaceutical CDMO Capacity
November 30, 2020 at 3:10 PM
News
Read More
2 min read
AGC Biologics and Horizon Therapeutics plc Expand Partnership
October 29, 2020 at 12:00 PM
News
Read More
1 min read
MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition
October 27, 2020 at 4:00 PM
News
Read More
2 min read
AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions
October 15, 2020 at 5:00 AM
News
Read More
2 min read
AGC Biologics Appoints Luca Alberici as the New General Manager/Site Head of the Milan, Italy Site
October 12, 2020 at 5:00 AM
News
Read More
2 min read
AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab
August 25, 2020 at 7:00 AM
News
Read More
1 min read
AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage
August 13, 2020 at 6:00 AM
News
Read More
2 min read
AGC Biologics Expands Partnership with Novavax
August 10, 2020 at 1:05 PM
News
Read More
1 min read
AGC to Complete the Acquisition of MolMed on July 31, 2020
July 27, 2020 at 7:00 PM
News
Read More
2 min read
AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program
July 8, 2020 at 10:00 PM
News
Read More
Prev
3
4
5
6
7
Next
